This systematic review and meta-analysis looked the impact of myopia (nearsightedness) and strabismus (misalignment of the eyes) on children.
Children with myopia (nearsightedness) and strabismus (misalignment of the eyes) often experience significantly reduced quality of life compared to those without vision impairment, finds a new study1 from Orbis International. Published in Ophthalmology, this systematic review and meta-analysis also finds that surgical treatment of strabismus improves quality of life among children, underscoring the importance of early detection, treatment, and health insurance coverage of strabismus for children.
The research received financial support from the Japanese pharmaceutical company Santen, according to a news release from Orbis International, a global nonprofit eye care nongovernmental organization.
Moreover, Orbis noted in its release quality of life and mental health are increasingly being recognized as important global health concerns. With an estimated 70 million children experiencing vision impairment around the world, understanding the impact of these conditions on mental health is critical.1
The company noted that a child's vision function is assessed by clarity or sharpness of their vision. However, this approach does not measure a child's perception of their own visual impairment and ability to successfully complete daily tasks. For example, chronic eye conditions that may not affect central vision but have other negative impacts, like strabismus, have been shown to cause physical, educational and socioemotional difficulties in their daily lives.
This research is a companion research study2 published last year by Orbis, and also published in Ophthalmology, that found children with myopia and strabismus were diagnosed with higher rates of depression and anxiety than children without vision impairment.
Nathan Congdon, M.D.
“Our papers in Ophthalmology furnish the strongest evidence yet that impaired vision in children is associated with mental health problems, such as depression and anxiety, Prof. Nathan Congdon, M.D., director of Research at Orbis International, said in the news release. “This latest study provides an even broader picture of a child's mental health, including quality of life, wellbeing, and self-esteem, meaning we now have a complete story about how a lack of vision care can cause mental health problems for a child.”
Briana Contreras, editor of Managed Healthcare Executive, spoke with Nancy Lurker, CEO and president of EyePoint Pharmaceuticals. Nancy shared a bit about EyePoint and how the organization’s innovative therapies are addressing patient needs through eye care, and most importantly, she addressed C-Suite positions like the CEO role. Nancy shared advice for those seeking to reach the CEO level, especially toward women in healthcare and other roles, and what it takes to run a biopharma company.
Listen
Positive Long-term Results Seen with Vabysmo in Retinal Vein Occlusion
October 10th 2023The FDA is currently reviewing a supplemental biologics license application for Vabysmo in patients with macular edema due to retinal vein occlusion. A decision from the FDA is expected in late 2023.
Read More
The authors of a case series reported in today's edition of JAMA Ophthalmology say silicone oil droplets from silicone used to lubricate the McKesson syringes is the most likely cause of the droplets presumed to cause the floaters. Of the 55 patients treated with Syfovre, 16 developed floaters.
Read More